KWEB vs XBI
KraneShares CSI China Internet ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.70% for KWEB.
- • KWEB pays a higher dividend yield (8.61%).
Side-by-side metrics
| Metric | KWEB | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.70% | 0.35% |
Dividend yield Trailing 12-month yield. | 8.61% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $4.91B | $10.73B |
YTD return | -22.44% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.88 | 1.10 |
P/E ratio | 12.86 | — |
Last price | $26.48 | $164.28 |
Inception | — | — |
Issuer | KraneShares | State Street |
KWEB top holdings
| 0700.HK | Tencent Holdings Ltd | 10.46% |
| PDD | PDD Holdings Inc ADR | 7.93% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 7.71% |
| 9999.HK | NetEase Inc Ordinary Shares | 6.98% |
| 3690.HK | Meituan Class B | 6.84% |
| 9888.HK | Baidu Inc | 4.20% |
| YMM | Full Truck Alliance Co Ltd ADR | 4.16% |
| 1024.HK | Kuaishou Technology Ordinary Shares - Class B | 4.08% |
| 2423.HK | KE Holdings Inc Class A | 3.90% |
| 9618.HK | JD.com Inc Ordinary Shares - Class A | 3.88% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About KWEB
KWEB (KraneShares CSI China Internet ETF) is Chinese internet and e-commerce companies. Managed by KraneShares, the fund carries $4.9B in assets under management, an expense ratio of 0.70%, a dividend yield of 8.61%. Its largest holding is Tencent Holdings Ltd (0700.HK), which represents 10.5% of the portfolio. Real Estate is the fund's largest sector exposure at 3.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.